Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Equity Ratio: 2011-2025

Historic Equity Ratio for Adma Biologics (ADMA) over the last 11 years, with Sep 2025 value amounting to 0.76.

  • Adma Biologics' Equity Ratio rose 27.72% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 27.72%. This contributed to the annual value of 0.71 for FY2024, which is 73.89% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Equity Ratio is 0.76, which was up 6.29% from 0.71 recorded in Q2 2025.
  • Adma Biologics' Equity Ratio's 5-year high stood at 0.76 during Q3 2025, with a 5-year trough of 0.33 in Q3 2022.
  • Its 3-year average for Equity Ratio is 0.56, with a median of 0.50 in 2024.
  • Per our database at Business Quant, Adma Biologics' Equity Ratio declined by 22.45% in 2022 and then soared by 73.89% in 2024.
  • Over the past 5 years, Adma Biologics' Equity Ratio (Quarterly) stood at 0.51 in 2021, then fell by 14.66% to 0.44 in 2022, then dropped by 5.82% to 0.41 in 2023, then skyrocketed by 73.89% to 0.71 in 2024, then rose by 27.72% to 0.76 in 2025.
  • Its Equity Ratio stands at 0.76 for Q3 2025, versus 0.71 for Q2 2025 and 0.73 for Q1 2025.